These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12049186)

  • 21. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
    Saku K; Cedres C; McDonald B; Hynd BA; Liu BW; Srivastava LS; Kashyap ML
    Am J Med; 1984 Sep; 77(3):457-62. PubMed ID: 6475985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed postprandial retinyl palmitate and squalene removal in a patient heterozygous for apolipoprotein A-IFIN mutation (Leu 159-->Arg) and low HDL cholesterol level without coronary artery disease.
    Gylling H; Relas H; Miettinen HE; Radhakrishnan R; Miettinen TA
    Atherosclerosis; 1996 Dec; 127(2):239-43. PubMed ID: 9125314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
    Nordestgaard BG; Langsted A; Mora S; Kolovou G; Baum H; Bruckert E; Watts GF; Sypniewska G; Wiklund O; Borén J; Chapman MJ; Cobbaert C; Descamps OS; von Eckardstein A; Kamstrup PR; Pulkki K; Kronenberg F; Remaley AT; Rifai N; Ros E; Langlois M;
    Eur Heart J; 2016 Jul; 37(25):1944-58. PubMed ID: 27122601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of apolipoproteins on the anatomical distribution of arterial disease.
    Wiseman SA; Powell JT; Barber N; Humphries SE; Greenhalgh RM
    Atherosclerosis; 1991 Aug; 89(2-3):231-7. PubMed ID: 1686549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia.
    Annuzzi G; Holmquist L; Carlson LA
    Scand J Clin Lab Invest; 1989 Feb; 49(1):73-81. PubMed ID: 2727620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation of plasma glucose levels to serum lipids and apolipoproteins levels in middle and old age males].
    Duan Y; Wu Z; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):382-4. PubMed ID: 12536570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Apolipoprotein C-II deficiency].
    Inadera H
    Nihon Rinsho; 1994 Dec; 52(12):3241-5. PubMed ID: 7853717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency.
    Catapano AL; Mills GL; Roma P; La Rosa M; Capurso A
    Clin Chim Acta; 1983 Jun; 130(3):317-27. PubMed ID: 6872264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
    Nordestgaard BG; Langsted A; Mora S; Kolovou G; Baum H; Bruckert E; Watts GF; Sypniewska G; Wiklund O; Borén J; Chapman MJ; Cobbaert C; Descamps OS; von Eckardstein A; Kamstrup PR; Pulkki K; Kronenberg F; Remaley AT; Rifai N; Ros E; Langlois M;
    Clin Chem; 2016 Jul; 62(7):930-46. PubMed ID: 27235445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new case of apo C-II deficiency with a nonsense mutation in the apo C-II gene.
    Zanelli T; Catapano AL; Averna MR; Barbagallo CM; Liotta A; Giardina FC; Notarbartolo A
    Clin Chim Acta; 1994 Jan; 224(2):111-8. PubMed ID: 8004780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism.
    Beil FU; Fojo SS; Brewer HB; Greten H; Beisiegel U
    Eur J Clin Invest; 1992 Feb; 22(2):88-95. PubMed ID: 1349286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.
    Wang R; Zhao C; Chen W; Liu Z; Xie F
    J Med Case Rep; 2022 Feb; 16(1):78. PubMed ID: 35193676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.
    Meyer E; Westerveld HT; de Ruyter-Meijstek FC; van Greevenbroek MM; Rienks R; van Rijn HJ; Erkelens DW; de Bruin TW
    Atherosclerosis; 1996 Aug; 124(2):221-35. PubMed ID: 8830935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency.
    Twickler TB; Wilmink HW; Schreuder PC; Cabezas MC; van Dam PS; Koppeschaar HP; Erkelens DW; Dallinga-Thie GM
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4683-9. PubMed ID: 11134128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis.
    Uiterwaal CS; Grobbee DE; Witteman JC; van Stiphout WA; Krauss XH; Havekes LM; de Bruijn AM; van Tol A; Hofman A
    Ann Intern Med; 1994 Oct; 121(8):576-83. PubMed ID: 8085689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study).
    Tiret L; Gerdes C; Murphy MJ; Dallongeville J; Nicaud V; O'Reilly DS; Beisiegel U; De Backer G
    Eur J Clin Invest; 2000 Jul; 30(7):578-85. PubMed ID: 10886297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.